Rabeprazole (RAB) provides greater day 1 heartburn (HB) relief than omeprazole (OME) in patients with acute erosive esophagitis (EE) and moderate to severe symptoms

Fitzgerald, Stephen; Krause, Richard; Schwartz, Howard; Lovett, Gareth; Mao, Lian; Hasner, Diane; DeLemos, Byron
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS8
Academic Journal
An abstract of the article "Rabeprazole (RAB) Provides Greater Day 1 Heartburn (HB) Relief Than Omeprazole (OME) in Patients With Acute Erosive Esophagitis (EE) and Moderate to Severe Symptoms," by Richard Krause, Howard Schwartz, Gareth Lovett, and Lian Mao is presented.


Related Articles

  • Antisecretory for short-term treatment of benign gastric ulcers.  // Modern Medicine;May96, Vol. 64 Issue 5, p28 

    Reports on the use of the drug omeprazole for the short-term treatment of benign gastric ulcers. Dosage; Other indications.

  • New indication for omeprazole.  // Drug Topics;4/8/96, Vol. 140 Issue 7, p8 

    Cites the approval given by United States Food and Drug Administration to Prilosec, generically known as omeprazole, to be used in the short-term treatment of gastric ulcers.

  • Lansoprazole/omeprazole.  // Reactions Weekly;4/14/2012, Issue 1397, p21 

    The article describes the case of a 63-year-old man who developed hypomgnesemia and seizures while receiving omeprazole and lanzoprazole for esophagitis and duodenitis.

  • Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Sharma, B.K.; Santana, I.A.; Wood, E.C.; Walt, R.P.; Pereira, M.; Noone, P.; Smith, P.L.R.; Walters, C.L.; Pounder, R.E. // British Medical Journal (Clinical Research Edition);9/22/1984, Vol. 289 Issue 6447, p717 

    Investigates the intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole. Decrease of intragastric acidity; Forecast for the survival of oral bacteria in saliva; Characterization of the intragastric bacteria in forming N-nitroso compounds.

  • “Me Too” Products – Friend or Foe?  // New England Journal of Medicine;4/8/2004, Vol. 350 Issue 15, p1586 

    This article resents a correction to an article in the January 15, 2004, issue regarding the proton-pump inhibitor.

  • Room to improve omeprazole prescribing in Oman.  // PharmacoEconomics & Outcomes News;7/16/2011, Issue 633, p10 

    The article focuses on a study of omeprazole prescribing in Oman conducted by R. Vaishnav and colleagues and presented at the 10th Congress of the European Association for Clinical Pharmacoloty and Therapeutics in 2011.

  • Omeprazole reduces the antiplatelet effect of clopidogrel.  // Australian Journal of Pharmacy;Jun2011, Vol. 92 Issue 1093, p82 

    The article reports on the result of a study that shows that omeprazole significantly reduces the antiplatelet effect of clopidogrel.

  • Omeprazole.  // Reactions Weekly;7/9/2011, Issue 1359, p29 

    The article describes the case of a male neonate who developed bilateral gynaecomastia induced by omeprazole use.

  • ERRATUM.  // American Journal of Gastroenterology;Jul1994, Vol. 89 Issue 7, p1135 

    Presents a correction to the article "Four-Week Treatment with Omeprazole Increases the Metabolism of Caffeine" that was previously published in the March 1994 issue of "The American Journal of Gastroenterology."

  • Omeprazole.  // Reactions Weekly;7/31/2010, Issue 1312, p36 

    The article describes the case of four patients who developed anaphylaxis and a patient who developed generalized urticaria while receiving omeprazole treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics